The use of urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin for diagnosis of hepato-renal syndrome in advanced cirrhotic patients

被引:0
|
作者
Elaziz, Mohamed Adel Abd [1 ]
Elewa, Asmaa Mustafa Gouda [2 ]
Hamid, Dina Zaki Mohamed Zaki Abdel [3 ]
Hassan, Nohier Essam Soliman Ahmed [4 ]
Csongradi, Eva [5 ]
Mohammed, Emad Hamdy Hamouda [6 ]
Gawad, Mohammed Abdel [7 ]
机构
[1] Alexandria Univ, Fac Med, Trop Med Dept, Alexandria, Egypt
[2] Alexandria Univ, Fac Med, Dept Clin & Chem Pathol, Alexandria, Egypt
[3] Alexandria Hepatol Gastroenterol & Fever Hosp, Alexandria, Egypt
[4] Zamzam Hosp, Alexandria, Egypt
[5] Univ Debrecen, Fac Med, Debrecen, Hungary
[6] Alexandria Univ, Fac Med, Alexandria, Egypt
[7] Newgiza NGU Univ, Sch Med, Internal Med Dept, Nephrol Unit, Giza, Egypt
关键词
Hepatorenal syndrome; neutrophil gelatinase-associated lipocalin; urinary kidney injury molecule-1; serum creatinine; liver cirrhosis; DIFFERENTIAL-DIAGNOSIS; BIOMARKERS; SERUM;
D O I
10.1080/0886022X.2024.2346284
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
BackgroundChronic liver disease is a common and important clinical problem.Hepatorenal syndrome (HRS) is a life threatening complication. Serum creatinine (Cr) remains the only conventional indicator of renal function. However, the interpretation of serum Cr level can be confounded by malnutrition and reduced muscle mass often observed in patients with severe liver disease. Here, we present a cross-sectional study to explore the sensitivity and specificity of other markers as urinary KIM-1 and NGAL for cases of HRS.MethodsCross-sectional study was conducted on 88 patients who were admitted to Alexandria main university hospital. Enrolled patients were divided in two groups; group 1: patients with advanced liver cirrhosis (child B and C) who have normal kidney functions while group 2: patients who developed HRS. Stata (c) version 14.2 software package was used for analysis.ResultsGroup 1 included 18 males and 26 females compared to 25 males and 19 females in group 2 (p = 0.135). Only the urinary KIM-1 showed a statistically significant difference between both groups in the multivariate logistic regression analysis adjusted for gender, serum bilirubin, serum albumin, INR, serum K, AST and ALT levels.ConclusionIn conclusion, our study aligns with prior research, as seen in the consistent findings regarding Urinary NGAL elevation in cirrhotic patients with AKI. Urinary KIM-1, independent of Urinary NGAL, may have a role in precisely distinguishing between advanced liver cirrhosis and HRS and merits further exploration.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Urinary Neutrophil Gelatinase-Associated Lipocalin in Cirrhotic Patients with Acute Kidney Injury
    Hamdy, Hassan S.
    El-Ray, Ahmed
    Salaheldin, Mohamed
    Lasheen, Mohammad
    Aboul-Ezz, Mohamed
    Abdel-Moaty, Ahmed S.
    Abdel-Rahim, Ali
    ANNALS OF HEPATOLOGY, 2018, 17 (04) : 624 - 630
  • [2] Sensitivity and Specificity of Urinary Neutrophil Gelatinase-Associated Lipocalin and Kidney Injury Molecule-1 for the Diagnosis of Renal Cell Carcinoma
    Morrissey, Jeremiah J.
    London, Amy N.
    Lambert, Matthew C.
    Kharasch, Evan D.
    AMERICAN JOURNAL OF NEPHROLOGY, 2011, 34 (05) : 391 - 398
  • [3] Effect of continuous renal replacement therapy on kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin in patients with septic acute kidney injury
    Shao, Yiming
    Fan, Yinqiang
    Xie, Yuliu
    Yin, Lu
    Zhang, Yuanli
    Deng, Liehua
    Sun, Xiaocong
    Shao, Xin
    Tan, Xinzhang
    He, Junbing
    Zhao, Shiman
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 13 (06) : 3594 - 3602
  • [4] Evaluation of urinary neutrophil gelatinase-associated lipocalin and urinary kidney injury molecule-1 as biomarkers of renal function in cancer patients treated with cisplatin
    Ghadrdan, Elliyeh
    Ebrahimpour, Sholeh
    Sadighi, Sanambar
    Chaibakhsh, Samira
    Jahangard-Rafsanjani, Zahra
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (07) : 1643 - 1649
  • [5] Diagnostic performance of urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin for acute kidney injury in an obstructive nephropathy patient
    Xue, Wei
    Xie, Yuanyuan
    Wang, Qin
    Xu, Weijia
    Mou, Shan
    Ni, Zhaohui
    NEPHROLOGY, 2014, 19 (04) : 186 - 194
  • [6] Clinical implication of urinary neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 in patients with acute paraquat intoxication
    Gil, Hyo-Wook
    Yang, Jong-Oh
    Lee, Eun-Young
    Hong, Sae-Yong
    CLINICAL TOXICOLOGY, 2009, 47 (09) : 870 - 875
  • [7] Urinary neutrophil gelatinase-associated lipocalin: Acute kidney injury in liver cirrhosis
    Mohan, Pooja Basthi
    Nagaraju, Shankar Prasad
    Rangaswamy, Dharshan
    Musunuri, Balaji
    Attur, Ravindra Prabhu
    Bhat, Ganesh
    Shailesh
    Shetty, Shiran
    CLINICA CHIMICA ACTA, 2021, 523 : 339 - 347
  • [8] Urinary calprotectin, kidney injury molecule-1, and neutrophil gelatinase-associated lipocalin for the prediction of adverse outcome in pediatric acute kidney injury
    Westhoff, Jens H.
    Seibert, Felix S.
    Waldherr, Sina
    Bauer, Frederic
    Toenshoff, Burkhard
    Fichtner, Alexander
    Westhoff, Timm H.
    EUROPEAN JOURNAL OF PEDIATRICS, 2017, 176 (06) : 745 - 755
  • [9] Urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as indicators of tubular damage in normoalbuminuric patients with type 2 diabetes
    de Carvalho, Jose Antonio M.
    Tatsch, Etiane
    Hausen, Bruna S.
    Bollick, Yanai S.
    Moretto, Maria B.
    Duarte, Thiago
    Duarte, Marta M. M. F.
    Londero, Silvia W. K.
    Premaor, Melissa O.
    Comim, Fabio V.
    Delanghe, Joris R.
    Moresco, Rafael N.
    CLINICAL BIOCHEMISTRY, 2016, 49 (03) : 232 - 236
  • [10] The diagnostic and prognostic values of serum and urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin in sepsis induced acute renal injury patients
    Zhang, C. -F.
    Wang, H. -J.
    Tong, Z. -H.
    Zhang, C.
    Wang, Y. -S.
    Yang, H. -Q.
    Gao, R. -Y.
    Shi, H. -Z.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (10) : 5604 - 5617